Vivesto AB Cash Flow Conversion Efficiency

Latest as of June 2026: -0.051x

Vivesto AB cash flow conversion efficiency. Based on the latest financial reports, Vivesto AB (VIVE) has a cash flow conversion efficiency ratio of -0.051x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-8.11 Million ≈ $-872.98K USD) by net assets (Skr158.26 Million ≈ $17.03 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Vivesto AB (2004–2025)

Cash flow conversion efficiency of Vivesto AB from 2004 to 2025. This chart illustrates how Vivesto AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Vivesto AB (VIVE) share price today for real-time trading data and today's change.

Vivesto AB Cash Flow Conversion Ratio Explained

Vivesto AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Vivesto AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vivesto AB ranked by their cash flow conversion efficiency. Also see Vivesto AB stock valuation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Tractial S.A. PA:ALTRA	0.058x
SOLUTIANCE AG NA O.N. F:SLSA	N/A
Greenvale Energy Ltd AU:GRV	-0.058x
Alkali Metals Limited NSE:ALKALI	0.040x
XTL Biopharmaceuticals Ltd ADR NASDAQ:XTLB	7.898x
Goyal Aluminiums Limited NSE:GOYALALUM	0.036x
NEXE Innovations Inc V:NEXE	-0.026x
Origin Agritech Ltd F:39O1	N/A

Annual Cash Flow Conversion Efficiency for Vivesto AB (2004–2025)

The table below shows the annual cash flow conversion efficiency of Vivesto AB from 2004 to 2025. Review VIVE cash flow after capex ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr124.58 Million ≈ $13.41 Million	Skr-33.96 Million ≈ $-3.65 Million	-0.273x	+8.64%
2024-12-31	Skr158.33 Million ≈ $17.04 Million	Skr-47.25 Million ≈ $-5.08 Million	-0.298x	+14.14%
2023-12-31	Skr197.80 Million ≈ $21.29 Million	Skr-68.74 Million ≈ $-7.40 Million	-0.348x	-40.46%
2022-12-31	Skr325.42 Million ≈ $35.02 Million	Skr-80.52 Million ≈ $-8.66 Million	-0.247x	+6.56%
2021-12-31	Skr549.71 Million ≈ $59.16 Million	Skr-145.56 Million ≈ $-15.67 Million	-0.265x	+11.23%
2020-12-31	Skr686.74 Million ≈ $73.90 Million	Skr-204.86 Million ≈ $-22.05 Million	-0.298x	-3460.04%
2019-12-31	Skr819.39 Million ≈ $88.18 Million	Skr-6.87 Million ≈ $-738.89K	-0.008x	+97.01%
2018-12-31	Skr424.05 Million ≈ $45.63 Million	Skr-118.84 Million ≈ $-12.79 Million	-0.280x	+21.79%
2017-12-31	Skr345.04 Million ≈ $37.13 Million	Skr-123.63 Million ≈ $-13.30 Million	-0.358x	+19.08%
2016-12-31	Skr300.37 Million ≈ $32.32 Million	Skr-133.01 Million ≈ $-14.31 Million	-0.443x	-12.69%
2015-12-31	Skr326.05 Million ≈ $35.09 Million	Skr-128.13 Million ≈ $-13.79 Million	-0.393x	-37.13%
2014-12-31	Skr375.71 Million ≈ $40.43 Million	Skr-107.67 Million ≈ $-11.59 Million	-0.287x	+7.04%
2013-12-31	Skr281.91 Million ≈ $30.34 Million	Skr-86.90 Million ≈ $-9.35 Million	-0.308x	-41.47%
2012-12-31	Skr319.15 Million ≈ $34.35 Million	Skr-69.54 Million ≈ $-7.48 Million	-0.218x	-13.63%
2011-12-31	Skr273.47 Million ≈ $29.43 Million	Skr-52.44 Million ≈ $-5.64 Million	-0.192x	+2.07%
2010-12-31	Skr294.17 Million ≈ $31.66 Million	Skr-57.60 Million ≈ $-6.20 Million	-0.196x	-147.13%
2009-12-31	Skr141.80 Million ≈ $15.26 Million	Skr-11.23 Million ≈ $-1.21 Million	-0.079x	-133.97%
2008-12-31	Skr61.21 Million ≈ $6.59 Million	Skr14.28 Million ≈ $1.54 Million	0.233x	+167864.83%
2007-12-31	Skr64.81 Million ≈ $6.97 Million	Skr9.00K ≈ $968.54	0.000x	+100.07%
2006-12-31	Skr110.30 Million ≈ $11.87 Million	Skr-22.73 Million ≈ $-2.45 Million	-0.206x	-7.71%
2005-12-31	Skr58.90 Million ≈ $6.34 Million	Skr-11.27 Million ≈ $-1.21 Million	-0.191x	-192.02%
2004-12-31	Skr31.40 Million ≈ $3.38 Million	Skr6.53 Million ≈ $702.68K	0.208x	--

About Vivesto AB

ST:VIVE Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$8.80 Million

Skr81.82 Million SEK

Market Cap Rank

#27265 Global

#591 in Sweden

Share Price

Skr7.39

Change (1 day)

-1.47%

52-Week Range

Skr0.08 - Skr17.00

All Time High

Skr17.00